Terms: = Lung cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
352 results:
1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
[TBL] [Abstract] [Full Text] [Related]
3. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
[TBL] [Abstract] [Full Text] [Related]
4. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
[No Abstract] [Full Text] [Related]
5. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
[TBL] [Abstract] [Full Text] [Related]
6. CDK4/6 inhibitors in lung cancer: current practice and future directions.
Lv S; Yang J; Lin J; Huang X; Zhao H; Zhao C; Yang L
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355149
[TBL] [Abstract] [Full Text] [Related]
7. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
8. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
Miao Q; Zheng X; Li L; Zheng X; Zhang L; Jiang K; Wu S; Wang H; Wu B; Xu Y; Zhong Q; Zou Z; Zhang Q; Yang S; Li Y; Lin G
J Neurooncol; 2023 Dec; 165(3):517-525. PubMed ID: 38104049
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
11. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
[TBL] [Abstract] [Full Text] [Related]
12. Updates in Management of Malignant Pleural Mesothelioma.
John A; O'Sullivan H; Popat S
Curr Treat Options Oncol; 2023 Dec; 24(12):1758-1789. PubMed ID: 37975977
[TBL] [Abstract] [Full Text] [Related]
13. The Effect of Liraglutide on lung cancer and Its Potential Protective Effect on High Glucose-Induced lung Senescence and Oxidative Damage.
Pu Z; Yang Y; Qin S; Li X; Cui C; Chen W
Front Biosci (Landmark Ed); 2023 Oct; 28(10):259. PubMed ID: 37919054
[TBL] [Abstract] [Full Text] [Related]
14. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
[TBL] [Abstract] [Full Text] [Related]
15. Runx3 Restoration Regresses K-Ras-Activated Mouse lung cancers and Inhibits Recurrence.
Lee JY; Lee JW; Park TG; Han SH; Yoo SY; Jung KM; Kim DM; Lee OJ; Kim D; Chi XZ; Kim EG; Lee YS; Bae SC
Cells; 2023 Oct; 12(20):. PubMed ID: 37887282
[TBL] [Abstract] [Full Text] [Related]
16. Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators.
Volta F; La Monica S; Leonetti A; Gnetti L; Bonelli M; Cavazzoni A; Fumarola C; Galetti M; Eltayeb K; Minari R; Petronini PG; Tiseo M; Alfieri R
Target Oncol; 2023 Nov; 18(6):953-964. PubMed ID: 37855989
[TBL] [Abstract] [Full Text] [Related]
17. Sclareol induces cell cycle arrest and ROS-mediated apoptosis and ferroptosis in lung adenocarcinoma cells.
Rah B; Shafarin J; Hamad M; Muhammad JS
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23563. PubMed ID: 37850667
[TBL] [Abstract] [Full Text] [Related]
18. Mathematical Modeling of Oncolytic Virus Therapy Reveals Role of the Immune Response.
Guo E; Dobrovolny HM
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766219
[TBL] [Abstract] [Full Text] [Related]
19. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC.
Wamsley NT; Wilkerson EM; Guan L; LaPak KM; Schrank TP; Holmes BJ; Sprung RW; Gilmore PE; Gerndt SP; Jackson RS; Paniello RC; Pipkorn P; Puram SV; Rich JT; Townsend RR; Zevallos JP; Zolkind P; Le QT; Goldfarb D; Major MB
Mol Cell Proteomics; 2023 Nov; 22(11):100647. PubMed ID: 37716475
[TBL] [Abstract] [Full Text] [Related]
20. CBX4 deletion promotes tumorigenesis under Kras
Chen F; Hou W; Yu X; Wu J; Li Z; Xu J; Deng Z; Chen G; Liu B; Yin X; Yu W; Zhang L; Xu G; Ji H; Liang C; Wang Z
Signal Transduct Target Ther; 2023 Sep; 8(1):343. PubMed ID: 37696812
[TBL] [Abstract] [Full Text] [Related]
[Next]